...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
Reply New Message
Back To Forum List View
Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
2
coldnewfie
May 19, 2024 08:42AM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
1
narmac
May 19, 2024 08:53PM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
3
chicagoest
May 19, 2024 10:21PM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
1
KOO-KOO2
May 20, 2024 01:50PM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
2
chicagoest
May 20, 2024 02:03PM
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
1
KOO-KOO2
May 20, 2024 03:33PM

Just another failure!!,,,18 more to come possibly????,,,,,hahhahahaha...if these guys didnt have bad luck they would have no luck as is said!!!,,,we are so used to these results it doesnt even trigger heart fluctuations in me anymore!!,,

1 Recommendations
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
1
chicagoest
May 20, 2024 11:26PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply